Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects
暂无分享，去创建一个
N. Ford | A. Phillips | L. Mofenson | C. Moore | S. Khoo | P. Ehrenkranz | A. Hill | A. Ciaranello | G. Siberry | A. Pozniak | C. Thorne | H. Watts | M. Doherty | P. Clayden | E. Raizes | A. Fakoya | S. Modi | Imelda C Mahaka | Kenly Sikwese | Jacque Wambui | C. Moore | Imelda C Mahaka